TY - JOUR
T1 - High-dimensional analysis of the murine myeloid cell system
AU - Becher, Burkhard
AU - Schlitzer, Andreas
AU - Chen, Jinmiao
AU - Mair, Florian
AU - Sumatoh, Hermi R.
AU - Teng, Karen Wei Weng
AU - Low, Donovan
AU - Ruedl, Christiane
AU - Riccardi-Castagnoli, Paola
AU - Poidinger, Michael
AU - Greter, Melanie
AU - Ginhoux, Florent
AU - Newell, Evan W.
N1 - Funding Information:
The authors thank the SIgN community, the SIgN Flow Cytometry Facility and members of E.W.N.’s, F.G.’s and B.B.’s labs, and L.G. Ng for helpful discussion. Some antibodies used for generating the mass cytometry panels were provided by R. Balderas and A. Tiong (Becton Dickinson). The antibodies generated by BioXcell were provided for this analysis free of charge. B.B. performed this work while on sabbatical at A*STAR/SIgN. Supported by A*STAR/SIgN (P.R.-C., F.G., M.P., E.W.N.) and the Swiss National Science Foundation (PP03P3_144781 (M.G.), 316030_ 150768, 310030_146130 and CRSII3_136203 (B.B.)), European Union FP7 project TargetBraIn, NeuroKine, Advanced T-cell Engineered for Cancer Therapy (ATECT) and the University Research Priority Project ‘Translational Cancer Research’ (B.B.).
PY - 2014/11/18
Y1 - 2014/11/18
N2 - Advances in cell-fate mapping have revealed the complexity in phenotype, ontogeny and tissue distribution of the mammalian myeloid system. To capture this phenotypic diversity, we developed a 38-antibody panel for mass cytometry and used dimensionality reduction with machine learning-aided cluster analysis to build a composite of murine (mouse) myeloid cells in the steady state across lymphoid and nonlymphoid tissues. In addition to identifying all previously described myeloid populations, higher-order analysis allowed objective delineation of otherwise ambiguous subsets, including monocyte-macrophage intermediates and an array of granulocyte variants. Using mice that cannot sense granulocyte macrophage-colony stimulating factor GM-CSF (Csf2rb '/ '), which have discrete alterations in myeloid development, we confirmed differences in barrier tissue dendritic cells, lung macrophages and eosinophils. The methodology further identified variations in the monocyte and innate lymphoid cell compartment that were unexpected, which confirmed that this approach is a powerful tool for unambiguous and unbiased characterization of the myeloid system.
AB - Advances in cell-fate mapping have revealed the complexity in phenotype, ontogeny and tissue distribution of the mammalian myeloid system. To capture this phenotypic diversity, we developed a 38-antibody panel for mass cytometry and used dimensionality reduction with machine learning-aided cluster analysis to build a composite of murine (mouse) myeloid cells in the steady state across lymphoid and nonlymphoid tissues. In addition to identifying all previously described myeloid populations, higher-order analysis allowed objective delineation of otherwise ambiguous subsets, including monocyte-macrophage intermediates and an array of granulocyte variants. Using mice that cannot sense granulocyte macrophage-colony stimulating factor GM-CSF (Csf2rb '/ '), which have discrete alterations in myeloid development, we confirmed differences in barrier tissue dendritic cells, lung macrophages and eosinophils. The methodology further identified variations in the monocyte and innate lymphoid cell compartment that were unexpected, which confirmed that this approach is a powerful tool for unambiguous and unbiased characterization of the myeloid system.
UR - http://www.scopus.com/inward/record.url?scp=84911016319&partnerID=8YFLogxK
U2 - 10.1038/ni.3006
DO - 10.1038/ni.3006
M3 - Article
C2 - 25306126
AN - SCOPUS:84911016319
SN - 1529-2908
VL - 15
SP - 1181
EP - 1189
JO - Nature Immunology
JF - Nature Immunology
IS - 12
ER -